TY - CHAP M1 - Book, Section TI - Hypoglycemia A1 - Gomella, Tricia Lacy A1 - Cunningham, M. Douglas A1 - Eyal, Fabien G. A1 - Tuttle, Deborah J. Y1 - 2013 N1 - T2 - Neonatology: Management, Procedures, On-Call Problems, Diseases, and Drugs, 7e AB - An infant has a “low blood glucose level” on bedside glucose testing. The American Academy of Pediatrics (AAP) Committee on Fetus and Newborn states that the “absolute definition of hypoglycemia as a specific value or range cannot be given, as no evidence-based studies can define what clinically relevant neonatal hypoglycemia is.” Therefore, it is challenging to address treatment for hypoglycemia, as it is not possible to define a single blood glucose level that requires intervention in every newborn. Because blood glucose is lower in the first 12–24 hours after birth, some clinicians use a lower target number in the first 24 hours of life to define hypoglycemia. Treatment decisions depend on the clinical situation and infant characteristics. Note: Aggressive screening and treatment is recommended because hypoglycemia is linked to poor neurodevelopmental outcome. Incidence varies depending on many factors, including gestational age and cause, but is ∽15%. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesspediatrics.mhmedical.com/content.aspx?aid=1107527845 ER -